Em recrutamento
FASE
Número Europeu 2021-003369-37
D9077C00001- NeoCOAST-2
A Phase II, Open-label, Multicentre, Randomised Study of Neoadjuvant and Adjuvant Treatment in Patients With Resectable, Early-stage (II to IIIB) Non-small Cell Lung Cancer (NeoCOAST-2)
Detalhes
Destaques